Lenvima (Eisai Inc.)
Welcome to the PulseAid listing for the Lenvima drug offered from Eisai Inc.. This Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eisai Inc. |
| NON-PROPRIETARY NAME: | Lenvatinib |
| SUBSTANCE NAME: | LENVATINIB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-05-13 |
| END MARKETING DATE: | 0000-00-00 |
Lenvima HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lenvima from Eisai Inc. |
| LABELER NAME: | Eisai Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/1) |
| START MARKETING DATE: | 2016-05-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62856-708_948f83bf-3b18-48ef-b99e-8165632453e5 |
| PRODUCT NDC: | 62856-708 |
| APPLICATION NUMBER: | NDA206947 |
Other LENVATINIB Pharmaceutical Manufacturers / Labelers:
